• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human STEAP1 protein (STEAP1), Truncated

ACP00174

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP00174 Target NameSTEAP1
Target SynonymsSix-transmembrane epithelial antigen of prostate 1FormLiquid or Lyophilized powder
Expression SystemE.coliExpression Range3-69aa
Mol Weight39.5 kDaProtein LengthPartial
PurityGreater than 85% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ9UHE8
Background Information
  • Uniprot Id

    Q9UHE8

  • Target Species

    Human

  • Target Name

    STEAP1

  • Target Full Name

    STEAP1 protein

  • Target Function

    Metalloreductase that has the ability to reduce both Fe(3+) to Fe(2+) and Cu(2+) to Cu(1+). Uses NAD(+) as acceptor.

  • Target Subcellular Location

    Endosome membrane; Multi-pass membrane protein.

  • Target Protein Families

    STEAP family

  • Target Tissue Specificity

    Ubiquitously expressed. Highly expressed in prostate tumors.

  • Target Research Area

    Epigenetics and Nuclear Signaling, Transport

  • Target Synonyms

    STEAP1; PRSS24; STEAP; Metalloreductase STEAP1; Six-transmembrane epithelial antigen of prostate 1

  • Target Background

    This gene is predominantly expressed in prostate tissue, and is found to be upregulated in multiple cancer cell lines. The gene product is predicted to be a six-transmembrane protein, and was shown to be a cell surface antigen significantly expressed at cell-cell junctions.

Inquire Recombinant Human STEAP1 protein (STEAP1), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification